Gossamer Bio
GOSS
GOSS
133 hedge funds and large institutions have $664M invested in Gossamer Bio in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 42 increasing their positions, 42 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
133
Holders Change
+6
Holders Change %
+4.72%
% of All Funds
2.05%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
20
Increased
42
Reduced
42
Closed
13
Calls
$3.51M
Puts
$4.98M
Net Calls
-$1.47M
Net Calls Change
-$1.53M
Top Buyers
| 1 |
WP
1
Woodline Partners
San Francisco,
California
|
$11.1M |
| 2 |
2
Morgan Stanley
New York
|
$13.8M |
| 3 |
O
3
OrbiMed
New York
|
$7.73M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$37.2M |
| 5 |
5
Marshall Wace
London,
United Kingdom
|
$6.47M |
Top Sellers
| 1 |
ABG
1
Ally Bridge Group
New York
|
$5.37M |
| 2 |
2
Goldman Sachs
New York
|
$2.76M |
| 3 |
3
Millennium Management
New York
|
$2.36M |
| 4 |
PHP
4
Parkman Healthcare Partners
Stamford,
Connecticut
|
$6.18M |
| 5 |
IC
5
Ikarian Capital
Dallas,
Texas
|
$13.2M |
